Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 56.90% institutional investors, 4.00% insiders, and 39.10% retail investors. Blackrock is the largest institutional shareholder, holding 7.35% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xeris Biopharma | 56.90% | 4.00% | 39.10% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 10.33M | 7.35% | $23.25M |
| Blackrock funding, inc. /de | 10.82M | 7.26% | $36.68M |
| Vanguard group | 7.90M | 5.30% | $26.78M |
| State street | 3.26M | 2.32% | $7.33M |
| Geode capital management | 3.35M | 2.25% | $11.36M |
| Rosalind advisors | 3.10M | 2.08% | $10.53M |
| Renaissance | 2.10M | 1.41% | $7.12M |
| Millennium management | 1.95M | 1.31% | $6.61M |
| Nuveen asset management | 1.90M | 1.28% | $6.45M |
| Ubs group | 1.73M | 1.16% | $5.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 3.10M | 5.38% | $10.53M |
| Knott david m jr | 1.00M | 1.23% | $3.39M |
| Stonepine capital management | 182.32K | 0.50% | $618.05K |
| Essex investment management | 474.95K | 0.29% | $1.61M |
| Parkman healthcare partners | 578.51K | 0.26% | $1.96M |
| Centerbook partners lp | 690.08K | 0.14% | $2.34M |
| Alpine global management | 160.00K | 0.13% | $542.40K |
| Eam investors | 222.38K | 0.11% | $753.86K |
| Redmile group | 451.10K | 0.11% | $1.53M |
| Entrypoint capital | 52.76K | 0.08% | $178.86K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 1.73M | 0.00% | 1.45M |
| Goldman sachs group | 1.59M | 0.00% | 754.14K |
| Jpmorgan chase | 1.04M | 0.00% | 651.48K |
| Millennium management | 1.95M | 0.00% | 502.85K |
| Renaissance | 2.10M | 0.01% | 500.12K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -4.83M |
| Centerbook partners lp | 690.08K | 0.14% | -2.79M |
| Aigh capital management | - | - | -2.57M |
| Caxton | - | - | -2.02M |
| Walleye capital | - | - | -1.12M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Essex investment management | 474.95K | 0.29% | 474.95K | $1.61M |
| Eam investors | 222.38K | 0.11% | 222.38K | $753.86K |
| Stonepine capital management | 182.32K | 0.50% | 182.32K | $618.05K |
| Legato capital management | 142.16K | 0.06% | 142.16K | $481.94K |
| Globeflex capital l p | 125.21K | 0.04% | 125.21K | $424.46K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -27.00 |
| American capital advisory | -50.00 |
| Stephens consulting | -65.00 |
| Soa wealth advisors, llc. | -118.00 |
| Comerica bank | -417.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 204 | 24.39% | 86,739,126 | 32.43% | 56 | 2.94% | 129 | 46.59% | 39 | 14.71% |
| Dec 31, 2024 | 68 | -53.42% | 28,055,641 | -56.11% | 18 | 1.02% | 34 | -53.42% | 9 | -73.53% |
| Sep 30, 2024 | 143 | 4.38% | 63,815,802 | 5.21% | 42 | 2.30% | 71 | 1.43% | 34 | -5.56% |
| Jun 30, 2024 | 137 | -6.16% | 60,658,095 | 0.07% | 43 | 2.32% | 70 | -17.65% | 36 | 9.09% |
| Mar 31, 2024 | 146 | 19.67% | 60,615,681 | 1.47% | 43 | 2.31% | 85 | 49.12% | 33 | 6.45% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.90M | 3.13% | 645.00K |
| Vanguard US Total Market Shares ETF | 4.25M | 2.76% | - |
| iShares Russell 2000 ETF | 3.57M | 2.21% | -67.83K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.51M | 1.60% | 126.34K |
| CREF Stock R1 | 1.48M | 0.96% | - |
| Fidelity Small Cap Index | 1.42M | 0.91% | 4.86K |
| iShares Russell 2000 Growth ETF | 1.33M | 0.82% | - |
| Nuveen Quant Small Cap Equity R6 | 1.18M | 0.73% | -23.45K |
| Fidelity Extended Market Index | 858.12K | 0.55% | 45.74K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 840.13K | 0.52% | 4.09K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 12, 2025 | HALKUFF DAWN | - | Sell | $309.23K |
| Jun 13, 2025 | McCulloch Kevin | See Remarks | Buy | $109.47K |
| Mar 20, 2025 | Hecht Beth | See Remarks | Sell | $217.24K |
| Aug 12, 2024 | Schmid John P. | - | Buy | $10.15K |
| Aug 09, 2024 | Schmid John P. | - | Buy | $10.13K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | - |
| 2024 Q3 | 2 | - |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools